Spyre Therapeutics Inc (SYRE) ニュース

Form EFFECT - Notice of Effectiveness

Form POS AM - Post-Effective amendments for registration statement

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., March 7, 2025 WALTHAM...

Form S-3 - Registration statement under Securities Act of 1933

Form S-8 - Securities to be offered to employees in employee benefit plans

Form 8-K - Current report

Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update

Spyre Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate...

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Spyre Therapeutics to Participate in Upcoming March Investor Conferences

Spyre Therapeutics to Participate in Upcoming March Investor Conferences PR Newswire WALTHAM, Mass., Feb. 25...

Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis Organisation

Spyre Therapeutics Announces Poster Presentation at the 20th Congress of the European Crohn's and Colitis...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Spyre Therapeutics Announces Grants of Inducement Awards

Spyre Therapeutics Announces Grants of Inducement Awards PR Newswire WALTHAM, Mass., Feb. 7, 2025 WALTHAM...

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities